SF1494 (Legislative Session 94 (2025-2026))

Revision requirement of tests to be administered for determining the presence of a heritable or congenital disorder

Related bill: HF1029

AI Generated Summary

This bill, presented in the Minnesota Senate, aims to update the process for determining which tests should be administered to spot heritable or congenital disorders in individuals. It requires the state's health commissioner to regularly update the list of tests based on the latest medical advancements, more effective testing methods, and other factors that could enhance public health. These updates must consider the reliability of test methods, the potential for treating or preventing related medical conditions, and the severity of these conditions. The updated list of tests must be recommended by a specific advisory committee, approved by the commissioner, and published in the State Register. Importantly, this process of list revision is set to bypass standard rulemaking procedures. Additionally, the bill specifies the inclusion of testing for metachromatic leukodystrophy (MLD), a particular genetic disorder, in the revised list.

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
February 16, 2025SenateFloorActionIntroduction and first reading
February 16, 2025SenateFloorActionReferred toHealth and Human Services

Citations

 
[
  {
    "analysis": {
      "added": [
        "A mandate to include metachromatic leukodystrophy (MLD) in the list of tests."
      ],
      "removed": [],
      "summary": "This bill modifies the requirements for the list of tests to be administered for determining the presence of heritable or congenital disorders under section 144.125.",
      "modified": [
        "Revises criteria for test inclusion, focusing on advances in medical science, and adequacy of detection methods."
      ]
    },
    "citation": "144.125"
  }
]